(Q53911399)
Statements
The influence of reduced liver blood flow on the pharmacokinetics and pharmacodynamics of recombinant tissue factor pathway inhibitor. (English)
Kemme MJ
Burggraaf J
Paulson S
Karim A
Lentjes EG
Childs A
Braeckman RA
Cohen AF
1 May 2000
67
5
504-511